8-K//Current report
NRX Pharmaceuticals, Inc. 8-K
Accession 0001437749-25-028949
$NRXPCIK 0001719406operating
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:33 PM ET
Size
242.2 KB
Accession
0001437749-25-028949
Documents
- 8-Knrxp20250912_8k.htmPrimary
FORM 8-K
- EX-99.1ex_861043.htm
EXHIBIT 99.1
- EX-101.SCHnrxp-20250908.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFnrxp-20250908_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABnrxp-20250908_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREnrxp-20250908_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHIChope.jpg
- GRAPHICnrxlogo.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001437749-25-028949-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLnrxp20250912_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001719406
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:33 PM ET
- Size
- 242.2 KB